J.W. Cole Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding GRTX
J.W. Cole Advisors's GRTX Position: Q2 2024 in Review
J.W. Cole Advisors sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 12,000 shares — an estimated $1.68K sold.
J.W. Cole Advisors first reported a position in GRTX in Q4 2023 and held it in 2 quarters. The position peaked at $1.75K in Q4 2023. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.
- J.W. Cole Advisors reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- J.W. Cole Advisors sold 12,000 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.68K.
- J.W. Cole Advisors first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
- J.W. Cole Advisors's Galera Therapeutics, Inc. Common Stock position peaked at $1.75K in Q4 2023.
- 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.
Based on J.W. Cole Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.